(2) ALSIP, IL / ACCESSWIRE / December 28, 2020 / Capstone Therapeutics (OTCQB:CAPS) ("the Company"): EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 24,900 SHARES OF THE COMPANY'S COMMON STOCK On December 21, 2020, BP Peptides, LLC ("Brookstone") exercised its right to convert $572,700 of accrued interest and secured debt into 24,900 shares of the Company's Common Stock (exercise price of $23/share). With this acquisition Brookstone now owns 43,441 shares of the Company's Common Stock or 54.8% of the 79,277 outstanding shares of the Company's Common Stock. This transactio...